Image Image Image Image Image Image Image Image Image Image
Доступ
Идти наверх

Идти наверх

As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration. (FALTA)
26/03/2013

Last modified: 17 June, 2019 - 16:07